Gastrointestinal Surgery — MCQs

Gastrointestinal Surgery Indian Medical PG Practice Questions and MCQs

Question 151: What is true about duodenal adenocarcinoma?

A. It is the commonest small intestinal tumor.
B. It arises from the periampullary region.
C. Jaundice and anemia are commonly found.
D. All of the above. (Correct Answer)

Explanation: **Explanation:** Duodenal adenocarcinoma is a rare but significant malignancy, and understanding its presentation is high-yield for NEET-PG. * **Option A (Commonest small intestinal tumor):** While small bowel cancers are rare overall, **adenocarcinoma** is the most common histological type of small intestinal malignancy (followed by carcinoid, lymphoma, and GIST). Within the small bowel, the **duodenum** is the most frequent site for these adenocarcinomas (approx. 50%). * **Option B (Periampullary region):** The majority of duodenal adenocarcinomas arise in the **second portion (D2)** of the duodenum, specifically in the periampullary region. This location is critical as it dictates the clinical presentation and surgical approach. * **Option C (Jaundice and anemia):** Because most tumors are periampullary, they often cause biliary obstruction leading to **obstructive jaundice**. Additionally, these tumors frequently ulcerate, leading to chronic occult blood loss and **iron deficiency anemia**. **Conclusion:** Since all three statements are clinically accurate, **Option D** is the correct answer. **Clinical Pearls for NEET-PG:** * **Risk Factors:** Strongly associated with Familial Adenomatous Polyposis (FAP), Lynch syndrome, and Celiac disease. * **Presentation:** "Double-duct sign" on imaging (dilatation of both CBD and pancreatic duct) may be seen if the tumor obstructs the Ampulla of Vater. * **Management:** The treatment of choice for tumors in the D1/D2 segment is a **Whipple’s procedure** (Pancreaticoduodenectomy). Segmental resection is only considered for distal (D3/D4) lesions. * **Prognosis:** Generally better than pancreatic cancer but worse than distal small bowel tumors.

Question 152: Which of the following statements about carcinoma of the esophagus is FALSE?

A. Most common in the lower third (Correct Answer)
B. Histologically, adenocarcinoma is the only type
C. Unrelated to tobacco chewing
D. It is more common in females

Explanation: **Explanation:** The question asks for the **FALSE** statement regarding carcinoma of the esophagus. While the provided answer key marks "Most common in the lower third" as correct (implying it is false), this requires nuanced understanding based on current epidemiological shifts. **1. Analysis of the Correct (False) Statement:** * **Option A (Most common in the lower third):** Historically, Squamous Cell Carcinoma (SCC) was the most common type worldwide, typically occurring in the **middle third**. However, in modern Western practice and increasing urban trends, **Adenocarcinoma** (occurring in the **lower third**) has become the most common type. In the context of standard surgical textbooks (like Bailey & Love), the middle third remains the most frequent site for SCC, which is still the dominant histological type globally. **2. Evaluation of Other Options:** * **Option B (Adenocarcinoma is the only type):** This is **False**. There are two major histological types: Squamous Cell Carcinoma (arising from the epithelium) and Adenocarcinoma (arising from Barrett’s esophagus). * **Option C (Unrelated to tobacco chewing):** This is **False**. Tobacco (smoking and chewing) is a major risk factor for SCC. * **Option D (More common in females):** This is **False**. Carcinoma of the esophagus shows a strong **male predominance** (approx. 3:1 to 4:1). *Note: In many competitive exams, if multiple statements are technically false, the most "factually incorrect" or "traditionally taught" point is selected. However, globally, the middle third is the most common site for SCC.* **Clinical Pearls for NEET-PG:** * **Most common site (Global/SCC):** Middle third. * **Most common site (Adenocarcinoma):** Lower third (associated with GERD/Barrett’s). * **Plummer-Vinson Syndrome:** Increases risk of SCC in the post-cricoid region (upper third). * **Investigation of Choice:** Upper GI Endoscopy + Biopsy. * **Staging Investigation:** Contrast-Enhanced CT (CECT) and Endoscopic Ultrasound (EUS) for T-staging.

Question 153: Which of the following is NOT true about short bowel syndrome?

A. Intestinal transit time is increased (Correct Answer)
B. Nutritional deficiency is present
C. Steatorrhea is present
D. None of the above

Explanation: **Explanation:** Short Bowel Syndrome (SBS) occurs when there is a functional or physical loss of a significant portion of the small intestine, leading to malabsorption. **1. Why Option A is the correct answer (The "NOT true" statement):** In SBS, the **intestinal transit time is decreased**, not increased. Because a large segment of the bowel is missing or bypassed, the food bolus moves rapidly through the remaining short segment. This rapid transit reduces the contact time between nutrients and the intestinal mucosa, severely impairing absorption. **2. Why the other options are wrong (They are TRUE statements):** * **Nutritional Deficiency (Option B):** This is a hallmark of SBS. The loss of surface area leads to macro- and micronutrient deficiencies (especially Vitamins B12, A, D, E, K, and minerals like Magnesium and Calcium). * **Steatorrhea (Option C):** This is frequently present. It occurs due to two reasons: first, the reduced surface area for fat absorption; and second, the loss of the terminal ileum leads to a depleted bile acid pool (as bile salts cannot be reabsorbed), resulting in impaired fat emulsification. **Clinical Pearls for NEET-PG:** * **Definition:** SBS usually manifests when there is less than **200 cm** of functional small bowel remaining in adults. * **Most Critical Site:** Loss of the **ileocecal valve** significantly worsens the prognosis as it leads to bacterial overgrowth (SIBO) and further decreases transit time. * **Adaptation:** The remaining bowel undergoes "intestinal adaptation" (villous hypertrophy) over 1–2 years to improve absorption. * **Management:** Initial management is TPN (Total Parenteral Nutrition), but the drug **Teduglutide** (a GLP-2 analogue) is now used to enhance mucosal growth.

Question 154: Which feature is pathognomonic of a pelvic abscess?

A. Bloody diarrhea.
B. Loose stools.
C. Mucous diarrhea. (Correct Answer)
D. Constipation.

Explanation: **Explanation:** The correct answer is **C. Mucous diarrhea.** **Pathophysiology:** A pelvic abscess typically occupies the Pouch of Douglas, where it lies in direct contact with the anterior wall of the rectum. The inflammatory mass acts as a local irritant to the rectal mucosa. This irritation triggers the goblet cells to hyper-secrete mucus and stimulates the defecation reflex (tenesmus). Consequently, the patient passes frequent, small-volume stools consisting primarily of mucus, often described as "spurious diarrhea." This classic clinical sign is considered pathognomonic because it specifically reflects the localized rectal irritation caused by a pelvic collection. **Analysis of Incorrect Options:** * **A. Bloody diarrhea:** This is characteristic of inflammatory bowel disease (Ulcerative Colitis), invasive bacterial infections (Dysentery), or ischemic colitis, rather than a localized abscess. * **B. Loose stools:** While pelvic abscesses cause increased frequency, "loose stools" is a non-specific term for watery diarrhea seen in gastroenteritis or malabsorption. It lacks the specific "mucus-only" characteristic of rectal irritation. * **D. Constipation:** While an ileus can occur with generalized peritonitis, a localized pelvic abscess specifically irritates the rectum, leading to increased frequency (tenesmus) rather than a lack of bowel movements. **High-Yield Clinical Pearls for NEET-PG:** * **Clinical Triad:** A pelvic abscess is often suspected when a patient with previous peritonitis (e.g., post-appendectomy) develops a **swinging pyrexia**, **pelvic heaviness**, and **mucous diarrhea**. * **Diagnosis:** The most important bedside examination is a **Digital Rectal Examination (DRE)**, which reveals a boggy, tender mass on the anterior rectal wall. * **Treatment:** The standard management is surgical drainage through the anterior rectal wall (**Proctotomy**) or the posterior vaginal fornix (**Colpotomy**), depending on where the mass is most prominent.

Question 155: Which of the following statements is false regarding ambulatory pH monitoring?

A. H2 blocking agents must be stopped 3 days prior.
B. Proton pump inhibitors must be stopped 14 days prior.
C. Sensitivity and specificity are approximately 70%. (Correct Answer)
D. It is performed before considering antireflux surgery.

Explanation: ### Explanation **Ambulatory pH monitoring** is considered the **"Gold Standard"** for diagnosing Gastroesophageal Reflux Disease (GERD). #### 1. Why Option C is False (The Correct Answer) The statement that sensitivity and specificity are approximately 70% is incorrect. In reality, ambulatory 24-hour pH monitoring is highly accurate, with a **sensitivity and specificity of approximately 90% to 96%**. It provides an objective measurement of esophageal acid exposure (DeMeester Score) and correlates symptoms with reflux episodes. #### 2. Analysis of Other Options * **Option A & B:** To obtain an accurate baseline of acid production, medications that suppress acid must be discontinued. **H2 blockers** (e.g., ranitidine) should be stopped **3 days** prior, while **Proton Pump Inhibitors (PPIs)** (e.g., omeprazole) require a longer washout period of **7 to 14 days** because of their irreversible binding to the proton pump. * **Option D:** pH monitoring is mandatory before **antireflux surgery** (e.g., Nissen Fundoplication) to confirm the diagnosis of GERD, especially in patients with atypical symptoms or those who do not respond to medical therapy. This ensures surgery is not performed for non-reflux-related esophageal disorders. #### 3. Clinical Pearls for NEET-PG * **DeMeester Score:** A composite score used to quantify reflux. A score **>14.72** is considered abnormal. * **Bravo pH Monitoring:** A wireless capsule version that allows for 48–96 hours of monitoring and is better tolerated by patients than the transnasal catheter. * **Indications:** Persistent symptoms despite PPI therapy, evaluation before surgery, and assessment of extra-esophageal symptoms (chronic cough, asthma). * **Impedance-pH Monitoring:** The preferred test for detecting **non-acid (alkaline) reflux**, which standard pH monitoring might miss.

Question 156: What is the first-line investigation for esophageal carcinoma?

A. X-ray
B. Barium meal
C. Endoscopy (Correct Answer)
D. 24 hours pH measurement

Explanation: **Explanation:** **1. Why Endoscopy is the Correct Answer:** Upper Gastrointestinal (GI) Endoscopy is the **gold standard** and first-line investigation for suspected esophageal carcinoma. Its primary advantage is direct visualization of the tumor, allowing the clinician to assess its location, extent, and morphology. Most importantly, it enables a **tissue biopsy**, which is mandatory for a definitive histopathological diagnosis (squamous cell vs. adenocarcinoma). **2. Analysis of Incorrect Options:** * **X-ray (Chest/Abdomen):** Plain radiographs are non-specific. While they might show secondary signs like a widened mediastinum or an air-fluid level in advanced cases, they cannot diagnose the malignancy. * **Barium Meal/Swallow:** Historically, Barium swallow was the initial test to identify the "apple-core" appearance or irregular strictures. However, it cannot provide a tissue diagnosis and may miss early mucosal lesions. It is now primarily used to map the length of a stricture that an endoscope cannot bypass. * **24-hour pH measurement:** This is the gold standard for diagnosing Gastroesophageal Reflux Disease (GERD). While chronic GERD is a risk factor for Barrett’s esophagus and subsequent adenocarcinoma, pH monitoring has no role in the direct diagnosis of an established malignancy. **3. Clinical Pearls for NEET-PG:** * **Investigation of Choice for Staging:** Contrast-Enhanced CT (CECT) of the chest and abdomen. * **Most accurate for T and N staging:** Endoscopic Ultrasound (EUS). * **Most accurate for Distant Metastasis:** PET-CT. * **Classic Presentation:** Progressive dysphagia (first for solids, then liquids) associated with significant weight loss. * **Gold Standard for Diagnosis:** Endoscopy + Biopsy.

Question 157: Which dye is used in chromoendoscopy for the detection of cancer?

A. Gentian violet
B. Toluidine blue
C. Hematoxylin and eosin
D. Methylene blue (Correct Answer)

Explanation: **Explanation:** Chromoendoscopy involves the topical application of dyes during endoscopy to enhance tissue characterization and identify dysplastic or malignant lesions that might be invisible under standard white-light imaging. **Why Methylene Blue is correct:** Methylene blue is an **absorptive (vital) stain**. It is actively taken up by the cytoplasm of normal intestinal-type epithelium (small bowel and colon). In the esophagus, it is particularly useful for identifying **Barrett’s esophagus** (specialized intestinal metaplasia) and detecting areas of high-grade dysplasia or early adenocarcinoma, which often show decreased or irregular staining patterns compared to surrounding tissue. **Analysis of Incorrect Options:** * **Gentian violet:** While used as a biological stain and antifungal agent, it is not standard for gastrointestinal chromoendoscopy. * **Toluidine blue:** This is a basic dye that stains nucleic acids. While used in the oral cavity to detect squamous cell carcinoma, it is less commonly used in GI endoscopy compared to Methylene blue or Lugol's iodine. * **Hematoxylin and eosin (H&E):** This is the standard stain used in **histopathology** laboratories to examine biopsy slides under a microscope; it cannot be used in vivo during a live endoscopic procedure. **Clinical Pearls for NEET-PG:** * **Classification of Dyes:** * **Absorptive (Vital):** Methylene blue, Lugol’s iodine (stains glycogen in normal squamous cells; used to find esophageal SCC). * **Contrast (Non-vital):** Indigo carmine (not absorbed; highlights mucosal topography/polyps). * **Reactive:** Congo red (detects acid-secreting areas). * **High-Yield:** Lugol’s iodine is the gold standard for **Squamous Cell Carcinoma** screening, while Methylene blue is preferred for **Barrett’s esophagus** and colonic screening.

Question 158: A patient presents with a recurrent duodenal ulcer of 2.5 cm size. What is the procedure of choice?

A. Truncal vagotomy and antrectomy (Correct Answer)
B. Truncal vagotomy and gastrojejunostomy
C. Highly selective vagotomy
D. Laparoscopic vagotomy and gastrojejunostomy

Explanation: **Explanation:** The management of a **recurrent duodenal ulcer**, especially one that is large (2.5 cm), requires a procedure with the lowest possible recurrence rate. **1. Why Option A is Correct:** **Truncal Vagotomy and Antrectomy (V+A)** is considered the "Gold Standard" for surgical management of recurrent or complicated peptic ulcers. It addresses the two main phases of gastric acid secretion: the cephalic phase (via vagotomy) and the gastric phase (by removing the G-cell-rich antrum). This combination offers the **lowest recurrence rate (approximately 1%)** among all peptic ulcer surgeries, making it the procedure of choice for recurrence or ulcers larger than 2 cm (giant ulcers). **2. Why Other Options are Incorrect:** * **Option B (TV + GJ):** This is primarily a drainage procedure used when there is gastric outlet obstruction. While it reduces acid, the recurrence rate is higher (approx. 10%) compared to antrectomy. * **Option C (Highly Selective Vagotomy):** While HSV has the lowest rate of post-gastrectomy complications (like dumping), it has the **highest recurrence rate (up to 15%)**. It is generally contraindicated in cases where an ulcer has already recurred or is very large. * **Option D (Laparoscopic V+GJ):** Similar to Option B, the approach (laparoscopic) does not change the fact that GJ is inferior to antrectomy for preventing further recurrence in this clinical scenario. **Clinical Pearls for NEET-PG:** * **Lowest Recurrence Rate:** Truncal Vagotomy + Antrectomy (~1%). * **Lowest Complication Rate:** Highly Selective Vagotomy (HSV). * **Most Common Complication of TV:** Diarrhea. * **Giant Duodenal Ulcer:** Defined as >2 cm; these carry a higher risk of perforation and malignancy, necessitating more definitive resection like antrectomy.

Question 159: What is the most common site for lymphoma in the gastrointestinal tract?

A. Stomach (Correct Answer)
B. Duodenum
C. Ileum
D. Rectum

Explanation: ### Explanation **Correct Option: A. Stomach** Primary gastrointestinal (GI) lymphoma is the most common site for extranodal lymphoma, accounting for approximately 30–40% of all extranodal cases. Within the GI tract, the **stomach** is the most frequent site (50–60%), followed by the small intestine and the colon. The majority of gastric lymphomas are Non-Hodgkin Lymphomas (NHL), specifically **MALToma** (Mucosa-Associated Lymphoid Tissue) or Diffuse Large B-Cell Lymphoma (DLBCL). The high incidence in the stomach is strongly associated with chronic *Helicobacter pylori* infection, which induces the formation of lymphoid tissue in the gastric mucosa. **Analysis of Incorrect Options:** * **B. Duodenum:** This is the least common site for lymphoma in the small intestine. Small bowel lymphomas are more frequent in distal segments due to the higher concentration of lymphoid follicles (Peyer's patches). * **C. Ileum:** While the ileum is the most common site for lymphoma *within the small intestine* (due to the abundance of Peyer's patches), it ranks second to the stomach when considering the entire GI tract. * **D. Rectum:** Colorectal lymphomas are rare, accounting for less than 10% of GI lymphomas. They typically present in the cecum rather than the rectum. **High-Yield Clinical Pearls for NEET-PG:** * **Most common GI site for Lymphoma:** Stomach. * **Most common small bowel site for Lymphoma:** Ileum. * **Most common small bowel site for Adenocarcinoma:** Duodenum. * **Most common small bowel site for Carcinoid:** Ileum. * **Treatment Pearl:** Low-grade gastric MALToma can often be cured solely by *H. pylori* eradication therapy.

Question 160: Which artery is primarily involved in gastric ulcers?

A. Left gastric artery (Correct Answer)
B. Right gastric artery
C. Hepatic artery
D. Gastroduodenal artery

Explanation: **Explanation:** The **Left Gastric Artery (LGA)** is the correct answer because it is the primary blood supply to the **lesser curvature** of the stomach, which is the most common site for gastric ulcers. The LGA is a direct branch of the celiac trunk and is the largest artery supplying the stomach. When a gastric ulcer erodes through the posterior wall of the lesser curvature, it frequently involves the LGA, leading to significant upper gastrointestinal bleeding. **Analysis of Incorrect Options:** * **B. Right Gastric Artery:** While this artery also supplies the lesser curvature (anastomosing with the LGA), it is smaller and supplies the distal portion. It is less frequently the primary source of major hemorrhage compared to the LGA. * **C. Hepatic Artery:** This is a major branch of the celiac trunk that gives rise to the gastroduodenal and right gastric arteries but does not directly supply the gastric mucosa where ulcers typically form. * **D. Gastroduodenal Artery (GDA):** This is the most common artery involved in **duodenal ulcers** (specifically posterior duodenal ulcers). Erosion of a posterior bulb ulcer into the GDA is a classic cause of massive hematemesis. **Clinical Pearls for NEET-PG:** * **Gastric Ulcer:** Most common site is the **lesser curvature**; most common artery involved is the **Left Gastric Artery**. * **Duodenal Ulcer:** Most common site is the **first part of the duodenum (posterior wall)**; most common artery involved is the **Gastroduodenal Artery**. * **Dieulafoy’s Lesion:** Usually involves a large submucosal artery, most commonly located along the lesser curvature, often originating from the LGA.

Practice by Chapter

Esophageal Disorders

Practice Questions

Gastric Disorders

Practice Questions

Small Intestine Pathology

Practice Questions

Appendicitis

Practice Questions

Inflammatory Bowel Disease

Practice Questions

Intestinal Obstruction

Practice Questions

Gastrointestinal Bleeding

Practice Questions

Diverticular Disease

Practice Questions

Anorectal Disorders

Practice Questions

Colorectal Neoplasms

Practice Questions

Gastrointestinal Stomas

Practice Questions

Bariatric Surgery Principles

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free